Method for decreasing tumor metastasis
US4882318A · kind A · utility
17Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 24, 1987 |
| Grant date | Nov 21, 1989 |
| Priority date | — |
| Expiry date | Jun 24, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical compositions intended to decrease the incidence of tumor metastasis in patients who suffer from malignant diseases. The pharmaceutical compositions of the invention contain as active ingredient heparin or a suitable derivative thereof. Amongst suitable derivatives are N-desulfated and N-acetylated heparin. The dosage of the administered heparin or heparin derivative is quite critical and will generally be in the range of from 0.05 mg/kg/day to about 0.5 mg/kg/day. A preferred range is between about 0.1 mg/kg/day to about 0.5 mg/kg/day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.